In addition, KRT17 can activate different macrophage populations and subtypes (such as M1 and M2) through interferon γ, tumor necrosis factor-α and interleukin 10, which play an important role in tumor proliferation and differentiation (Sica and Mantovani, 2012). Here, KRT17 is linked to neoplasm.